These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26885106)

  • 1. Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI).
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Int J Clin Exp Med; 2015; 8(11):21565-71. PubMed ID: 26885106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Effect of Intravenous Calcitriol on the Ischemia-Reperfusion Process and Inflammatory Biomarkers in Patients Following Percutaneous Coronary Intervention (PCI).
    Dastan F; Salamzadeh J; Alipour-Parsa S; Sharif Kashani B; Hashempour MM
    Iran J Pharm Res; 2019; 18(Suppl1):282-290. PubMed ID: 32802107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis.
    Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
    PLoS One; 2017; 12(2):e0171682. PubMed ID: 28231287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-oxidative stress effect of loading-dose rosuvastatin prior to percutaneous coronary intervention in patients with acute coronary syndrome: a prospective randomized controlled clinical trial.
    Liang D; Zhang Q; Yang H; Zhang R; Yan W; Gao H; Wang J; Zhang X; Chen Y; Cao F
    Clin Drug Investig; 2014 Nov; 34(11):773-81. PubMed ID: 25186834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI.
    Balin M; Celik A; Kobat MA; Baydas A
    J Thromb Thrombolysis; 2012 Nov; 34(4):483-90. PubMed ID: 22797935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
    He W; Cao M; Li Z
    Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention.
    Jiang F; Yang J; Zhang L; Li R; Zhuo L; Sun L; Zhao Q
    Clin Cardiol; 2014 Sep; 37(9):530-5. PubMed ID: 25156269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155/SHIP-1 signaling pathway.
    Xie W; Li P; Wang Z; Chen J; Lin Z; Liang X; Mo Y
    Cardiovasc Ther; 2014 Dec; 32(6):276-82. PubMed ID: 25319951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
    Zhou FZ; Song W; Yin LH; Song ZF; Yang S; Yang FB; Liu JF; Song YG; Zhang HY; Zhang ZM
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4642-4648. PubMed ID: 29131250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.
    Shacham Y; Leshem-Rubinow E; Steinvil A; Keren G; Roth A; Arbel Y
    Clin Exp Nephrol; 2015 Oct; 19(5):838-43. PubMed ID: 25492251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
    Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
    Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
    Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.